Abstract
Bacterial transcription is a valid but underutilized target for antimicrobial agent discovery [1]. Nusbiarylins are the first-in-class bacterial ribosomal RNA synthesis inhibitors that possess potent activity against various types of multidrug-resistant bacteria with a novel mode of action by targeting the interaction of bacterial transcription factors NusB and NusE [2]. To facilitate the characterization of nusbiarylin derivatives produced by other researchers, high-performance liquid chromatography (HPLC) profiles, quantitative nuclear magnetic resonance (qNMR) and high-resolution mass spectrometry (HRMS) spectroscopic data were presented for the quick determination of purity and characterization of 95 nusbiarylin compounds. The data presented in this article supplement the 1H and 13C NMR data provided previously [3,4], and assist the reproduction of nusbiarylins for chemical, biological and drug discovery research.
Keywords: Inhibitor, Bacterial transcription, NusB-NusE interaction, HPLC, qNMR, HRMS
Specifications Table
| Subject | Chemistry |
| Specific subject area | Organic chemistry Analytical chemistry |
| Type of data | Table Figure |
| How data were acquired | Agilent 1100 series and 1260 infinity system Bruker ultrashield™ NMR spectrometer 600 MHz Agilent Technologies 6520 Accurate-Mass Q-TOF LC/MS spectrometer |
| Data format | Raw (as supplementary file) Analyzed |
| Parameters for data collection | The purified compounds were subjected to HPLC and qNMR analysis. The mobile phase for HPLC analysis were acetonitrile and water. The ratio was specified in the “Experimental Design, Materials, and Methods” section. The flow rate was set as 1.000 mL/min. Compounds were dissolved in d-DMSO prior to qNMR analysis. The parameters for qNMR analysis were adjusted according to the literature [5]. |
| Description of data collection | HPLC profiles of 95 novel compounds were recorded on and exported from an Agilent 1100 series and 1260 infinity system. Area% and RetTime stands for purity and retention time, respectively. qNMR spectra data of 95 novel compounds were recorded on and exported form a Bruker ultrashield™ NMR spectroscope 600 MHz spectrometer using standard Bruker pulse programs. Chemical shifts were shown as δ-values. Positive- and negative-ion HRESI-TOF-MS of 95 novel compounds were recorded on and exported from an Agilent Technologies 6520 Accurate-Mass Q-TOF LC/MS spectrometer. |
| Data source location | Department of Applied Biology and Chemical Technology, the Hong Kong Polytechnic University, Hong Kong SAR |
| Data accessibility | Data are available with the article |
Value of the Data
|
1. Data
Bacterial transcription is a valid but underutilized target for antimicrobial agent discovery [1]. NusB and NusE are bacteria-specific transcription factors essential for cell viability [1,2]. Inhibitors of the NusB-NusE interaction were discovered and named nusbiarylins. The name was derived from the target protein NusB and their biaryl structure [[2], [3], [4]]. The dataset contains high-performance liquid chromatography (HPLC) profiles of 90 compounds, quantitative nuclear magnetic resonance (qNMR) spectroscopic data of 5 compounds and high-resolution mass spectrometry (HRMS) profiles of all 95 compounds [3,4]. The data file (HPLC, qNMR and HRMS spectra) is available publicly within this data article as a supplementary file. The compound structures were presented in Table 1, purities in Table 2 and HRMS data in Table 3. The testing methods and parameters of different compounds by HPLC, HRMS and qNMR were also described.
Table 1.
Chemical structures of 95 nusbiarylin compounds as NusB-NusE inhibitors.
Table 2.
Data on purities by HPLC or qNMR and retention time (HPLC) of nusbiarylin compounds.
| Compound | Purity/% | Retention time/min |
|---|---|---|
| 1 | 99.9 | 6.51 |
| 2 | 99.0 | 11.23 |
| 3 | 99.8 | 9.06 |
| 4 | 98.2 | 9.35 |
| 5 | 98.0 | 9.47 |
| 6 | 100.0 | 9.32 |
| 7 | 99.5 | 9.90 |
| 8 | 99.8 | 10.12 |
| 9 | 99.9 | 10.12 |
| 10 | 99.4 | 12.10 |
| 11 | 100.0 | 12.35 |
| 12 | 99.2 | 12.50 |
| 13 | 96.0 | 5.66 |
| 14 | 97.8 | 6.59 |
| 15 | 96.1 | 6.35 |
| 16 | 98.5 | 10.17 |
| 17 | 96.6 | 10.51 |
| 18 | 95.5 | 10.50 |
| 19 | 97.8 | 7.80 |
| 20 | 98.7 | 9.04 |
| 21 | 99.9 | 9.02 |
| 22 | 98.4 | qNMR |
| 23 | 97.2 | 9.15 |
| 24 | 98.9 | qNMR |
| 25 | 100.0 | 10.09 |
| 26 | 98.3 | 10.55 |
| 27 | 97.3 | qNMR |
| 28 | 97.4 | 8.98 |
| 29 | 97.0 | 9.76 |
| 30 | 95.5 | 9.69 |
| 31 | 95.3 | 5.95 |
| 32 | 97.2 | 5.77 |
| 33 | 91.0 | qNMR |
| 34 | 99.2 | 9.21 |
| 35 | 100.0 | 7.86 |
| 36 | 99.4 | 6.48 |
| 37 | 99.7 | 6.81 |
| 38 | 97.7 | 6.70 |
| 39 | 99.8 | 6.58 |
| 40 | 99.8 | 7.14 |
| 41 | 100.0 | 7.11 |
| 42 | 98.0 | 7.17 |
| 43 | 99.4 | 8.67 |
| 44 | 98.6 | 8.92 |
| 45 | 99.6 | 9.15 |
| 46 | 96.3 | 5.25 |
| 47 | 99.3 | 4.70 |
| 48 | 99.5 | 7.45 |
| 49 | 99.3 | 7.35 |
| 50 | 99.7 | 7.32 |
| 51 | 98.9 | 6.82 |
| 52 | 99.7 | 6.27 |
| 53 | 97.6 | 6.05 |
| 54 | 99.6 | 7.44 |
| 55 | 98.0 | 6.21 |
| 56 | 99.6 | 5.80 |
| 57 | 99.4 | 7.84 |
| 58 | 99.0 | 7.72 |
| 59 | 97.6 | 7.68 |
| 60 | 98.7 | 6.79 |
| 61 | 99.4 | 4.33 |
| 62 | 98.9 | 12.92 |
| 63 | 98.1 | 9.85 |
| 64 | 97.1 | 9.87 |
| 65 | 99.4 | 9.02 |
| 66 | 97.7 | 8.46 |
| 67 | 97.6 | 9.46 |
| 68 | 99.8 | 9.68 |
| 69 | 99.9 | 9.32 |
| 70 | 99.8 | 9.62 |
| 71 | 97.2 | 9.73 |
| 72 | 98.0 | 8.46 |
| 73 | 95.1 | 7.03 |
| 74 | 97.7 | qNMR |
| 75 | 99.4 | 12.08 |
| 76 | 98.3 | 6.52 |
| 77 | 99.2 | 6.98 |
| 78 | 99.1 | 6.33 |
| 79 | 99.7 | 6.19 |
| 80 | 98.7 | 6.54 |
| 81 | 99.6 | 6.94 |
| 82 | 99.4 | 8.25 |
| 83 | 99.9 | 8.43 |
| 84 | 99.6 | 7.23 |
| 85 | 99.5 | 8.45 |
| 86 | 99.7 | 7.93 |
| 87 | 100.0 | 8.96 |
| 88 | 95.5 | 8.02 |
| 89 | 97.2 | 8.05 |
| 90 | 97.4 | 7.91 |
| 91 | 96.8 | 7.20 |
| 92 | 97.6 | 7.79 |
| 93 | 97.7 | 7.76 |
| 94 | 98.9 | 17.74 |
| 95 | 99.7 | 7.46 |
Table 3.
HRMS data of nusbiarylin compounds.
| Compound | Ion formula | m/z (calculated) | m/z (found) |
|---|---|---|---|
| 1 | C13H15N2O3 [M − H]- | 247.1088 | 247.1089 |
| 2 | C17H11N2O3 [M − H]- | 291.0775 | 291.0773 |
| 3 | C13H9N2O3 [M − H]- | 241.0619 | 241.0620 |
| 4 | C13H8FN2O3 [M − H]- | 259.0524 | 259.0523 |
| 5 | C13H8FN2O3 [M − H]- | 259.0524 | 259.0528 |
| 6 | C13H8FN2O3 [M − H]- | 259.0524 | 259.0522 |
| 7 | C14H11N2O3 [M − H]- | 255.0775 | 255.0771 |
| 8 | C14H11N2O3 [M − H]- | 255.0775 | 255.0772 |
| 9 | C14H11N2O3 [M − H]- | 255.0775 | 255.0772 |
| 10 | C17H17N2O3 [M − H]- | 297.1245 | 297.1247 |
| 11 | C17H17N2O3 [M − H]- | 297.1245 | 297.1242 |
| 12 | C17H17N2O3 [M − H]- | 297.1245 | 297.1243 |
| 13 | C13H9N2O4 [M − H]- | 257.0568 | 257.0565 |
| 14 | C13H9N2O4 [M − H]- | 257.0568 | 257.0568 |
| 15 | C13H9N2O4 [M − H]- | 257.0568 | 257.0567 |
| 16 | C13H8ClN2O3 [M − H]- | 275.0229 | 275.0227 |
| 17 | C13H8ClN2O3 [M − H]- | 275.0229 | 275.0226 |
| 18 | C13H8ClN2O3 [M − H]- | 275.0229 | 275.0226 |
| 19 | C14H11N2O4 [M − H]- | 271.0724 | 271.0719 |
| 20 | C14H11N2O4 [M − H]- | 271.0724 | 271.0721 |
| 21 | C14H11N2O4 [M − H]- | 271.0724 | 271.0727 |
| 22 | C15H11N2O5 [M − H]- | 299.0673 | 299.0672 |
| 23 | C15H11N2O5 [M − H]- | 299.0673 | 299.0669 |
| 24 | C15H11N2O5 [M − H]- | 299.0673 | 299.0672 |
| 25 | C14H8F3N2O3 [M − H]- | 309.0493 | 309.0492 |
| 26 | C14H8F3N2O3 [M − H]- | 309.0493 | 309.0491 |
| 27 | C14H8F3N2O3 [M − H]- | 309.0493 | 309.0490 |
| 28 | C15H9N2O3 [M − H]- | 265.0619 | 265.0618 |
| 29 | C15H9N2O3 [M − H]- | 265.0619 | 265.0620 |
| 30 | C15H9N2O3 [M − H]- | 265.0619 | 265.0615 |
| 31 | C14H11N2O4 [M − H]- | 271.0724 | 271.0721 |
| 32 | C14H11N2O4 [M − H]- | 271.0724 | 271.0722 |
| 33 | C14H9N2O5 [M − H]- | 285.0517 | 285.0513 |
| 34 | C13H17N2O3 [M − H]- | 249.1245 | 249.1245 |
| 35 | C17H13N2O3 [M − H]- | 293.0932 | 293.0929 |
| 36 | C13H11N2O3 [M − H]- | 243.0775 | 243.0775 |
| 37 | C13H10FN2O3 [M − H]- | 261.0681 | 261.0683 |
| 38 | C13H10FN2O3 [M − H]- | 261.0681 | 261.0679 |
| 39 | C13H10FN2O3 [M − H]- | 261.0681 | 261.0682 |
| 40 | C14H13N2O3 [M − H]- | 257.0932 | 257.0928 |
| 41 | C14H13N2O3 [M − H]- | 257.0932 | 257.0928 |
| 42 | C14H13N2O3 [M − H]- | 257.0932 | 257.0927 |
| 43 | C17H19N2O3 [M − H]- | 299.1401 | 299.1401 |
| 44 | C17H19N2O3 [M − H]- | 299.1401 | 299.1399 |
| 45 | C17H19N2O3 [M − H]- | 299.1401 | 299.1404 |
| 46 | C13H11N2O4 [M − H]- | 259.0724 | 259.0723 |
| 47 | C13H11N2O4 [M − H]- | 259.0724 | 259.0723 |
| 48 | C13H10ClN2O3 [M − H]- | 277.0385 | 277.0384 |
| 49 | C13H10ClN2O3 [M − H]- | 277.0385 | 277.0387 |
| 50 | C13H10ClN2O3 [M − H]- | 277.0385 | 277.0386 |
| 51 | C14H13N2O4 [M − H]- | 273.0881 | 273.0878 |
| 52 | C14H13N2O4 [M − H]- | 273.0881 | 273.0876 |
| 53 | C14H13N2O4 [M − H]- | 273.0881 | 273.0881 |
| 54 | C15H13N2O5 [M − H]- | 301.0830 | 301.0833 |
| 55 | C15H13N2O5 [M − H]- | 301.0830 | 301.0831 |
| 56 | C15H13N2O5 [M − H]- | 301.0830 | 301.0826 |
| 57 | C14H10F3N2O3 [M − H]- | 311.0649 | 311.0651 |
| 58 | C14H10F3N2O3 [M − H]- | 311.0649 | 311.0650 |
| 59 | C14H10F3N2O3 [M − H]- | 311.0649 | 311.0654 |
| 60 | C15H11N2O3 [M − H]- | 267.0775 | 267.0773 |
| 61 | C14H13N2O4 [M − H]- | 273.0881 | 273.0879 |
| 62 | C14H11N2O5 [M − H]- | 287.0673 | 287.0673 |
| 63 | C17H12NO3 [M − H]- | 278.0823 | 278.0822 |
| 64 | C15H9FNO [M − H]- | 238.0674 | 238.0672 |
| 65 | C16H9N2O [M − H]- | 245.0720 | 245.0719 |
| 66 | C17H11N2O [M − H]- | 259.0877 | 259.0876 |
| 67 | C16H12NO2 [M − H]- | 258.0874 | 258.0875 |
| 68 | C15H10NO [M − H]- | 220.0768 | 220.0772 |
| 69 | C15H11N2O2 [M + H]+ | 251.0815 | 251.0818 |
| 70 | C16H13N2O3 [M + H]+ | 281.0921 | 281.0922 |
| 71 | C15H9N2O3 [M − H]- | 265.0619 | 265.0620 |
| 72 | C15H9N2O3 [M − H]- | 265.0619 | 265.0616 |
| 73 | C15H9N2O3 [M − H]- | 265.0619 | 265.0621 |
| 74 | C15H8BrN2O3 [M − H]- | 342.9724 | 342.9727 |
| 75 | C15H8Cl2NO [M − H]- | 287.9988 | 287.9987 |
| 76 | C17H14NO3 [M − H]- | 280.0979 | 280.0974 |
| 77 | C15H11FNO [M − H]- | 240.0830 | 240.0829 |
| 78 | C16H11N2O [M − H]- | 247.0877 | 247.0876 |
| 79 | C17H13N2O [M − H]- | 261.1033 | 261.1032 |
| 80 | C16H14NO2 [M − H]- | 252.1030 | 252.1023 |
| 81 | C15H12NO [M − H]- | 222.0924 | 222.0923 |
| 82 | C15H13N2O2 [M + H]+ | 253.0972 | 253.0974 |
| 83 | C16H15N2O3 [M + H]+ | 283.1077 | 283.1080 |
| 84 | C15H11N2O3 [M − H]- | 267.0775 | 267.0773 |
| 85 | C15H11N2O3 [M − H]- | 267.0775 | 267.0770 |
| 86 | C15H10BrN2O3 [M − H]- | 344.9880 | 344.9878 |
| 87 | C15H10Cl2NO [M − H]- | 290.0145 | 290.0141 |
| 88 | C14H10NO3 [M − H]- | 240.0666 | 240.0662 |
| 89 | C15H12NO4 [M − H]- | 270.0772 | 270.0769 |
| 90 | C15H12NO4 [M − H]- | 270.0772 | 270.0771 |
| 91 | C15H9N2O3 [M − H]- | 265.0619 | 265.0617 |
| 92 | C16H12NO5 [M − H]- | 298.0721 | 298.0717 |
| 93 | C16H12NO5 [M − H]- | 298.0721 | 298.0719 |
| 94 | C15H9N2O4 [M − H]- | 281.0568 | 281.0571 |
| 95 | C13H8NO4 [M − H]- | 242.0459 | 242.0454 |
2. Experimental design, materials, and methods
2.1. HPLC analysis
2.1.1. Sample preparation and HPLC analysis
Approximately 0.1 mg of derivatives were dissolved in 1 mL of HPLC grade acetonitrile. 20 μL of supernatant was manually loaded onto the sample loop. The analysis was carried out on Agilent 1100 series and 1260 infinity system consisting of G1322A degasser, G1311A quat pump and G1365B multi-wavelength detector (MWD). The chromatographic parameters were set as follows:
Mobile phase: Mobile phase A: MeCN, Mobile phase B: H2O
Detector: MWD at 254 nm
Column: Agilent ZORBAX Eclipse Plus C18 (4.6 × 100 mm, 5 μm)
Flow rate: 1.000 mL/min
Gradient programme:
For compound 29, 60, 76, 87, 88
| t/min | Mobile phase A | Mobile phase B |
|---|---|---|
| 0 | 30% | 70% |
| 2 | 40% | 60% |
| 3 | 50% | 50% |
| 9 | 80% | 20% |
| 14 | 90% | 10% |
| 15 | 100% | 0% |
| 16.5 | 80% | 20% |
| 17 | 60% | 40% |
| 20 | 30% | 70% |
For compound 34, 62, 94
| t/min | Mobile phase A | Mobile phase B |
|---|---|---|
| 0 | 10% | 90% |
| 8 | 30% | 70% |
| 14 | 50% | 50% |
| 24 | 100% | 0% |
| 25 | 80% | 20% |
| 27 | 40% | 60% |
| 28 | 10% | 90% |
For the remaining compounds except compounds 22, 24, 27, 33, 74
| t/min | Mobile phase A | Mobile phase B |
|---|---|---|
| 0 | 30% | 70% |
| 2 | 40% | 60% |
| 3 | 50% | 50% |
| 13 | 100% | 0% |
| 16.5 | 30% | 70% |
2.1.2. Data processing
The automated integration software ChemStation for LC systems B.03.02 [341] was used to acquire the area under the curve (mAU). The obtained spectra were then exported as images.
2.2. qNMR analysis
2.2.1. Sample preparation and qNMR analysis
Samples were weighed into 5 mm standard NMR tubes using OHAUS® analytical plus balance, followed by addition of 500 μL of DMSO-d6 and indicated volume of internal reference 1,3,5-trioxane (99.66% pure, 9.98 mg/mL in DMSO-d6) purchased from Dieckmann (Hong Kong) Chemical Industry co., LTD. qNMR analysis were carried out via Bruker ultrashield™ NMR spectrometer 600 MHz. NMR instrument controlled parameters were adjusted as follows [5]:
Sample Temperature: 25 °C (298 K, regulated ± 0.1 K)
Data Points (acquired): 64 K
Zero-Filling (SI or FN): to 256 K
Dummy Scans: 4
Relaxation delay (D1): 60 s
Scans (NS or NT): 16
2.2.2. Data processing
The software Bruker topspin 3.2 was used to acquire the integrals of the signals of sample and internal reference. The normalized integrals values per proton equivalent by dividing each integral by the corresponding number of protons were calculated, so as the integral of the analyte (Intt and IntIC) as the average of all normalized integrals. The total number of protons (nt and nIC) was set to one [5]. Purities was then calculated according to the equation as below:
where: P = purity of tested compound
mIC = weight of the internal calibrant (IC)
ms = weight of the sample
IntIC = integral of the IC resonance signal being used for quantification
Intt = integral of the target analyte (t) resonance signal being used for quantification
nIC = number of protons that give rise to IntIC
nt = number of protons of the target analyte that give rise to Intt
MWIC = molecular weight of the internal calibrant
MWt = molecular weight of the target analyte
PIC = purity of the internal calibrant, as percent value
2.3. HRMS analysis for all compounds
2.3.1. Sample preparation and HRMS analysis
Approximately 0.1 mg of derivatives were dissolved in 1 mL of HPLC grade acetonitrile. After sonication and filtration via 0.22 μm PTFE syringe filter, 10 μL of the upper layer was injected using an autosampler onto Agilent Technologies 6520 Accurate-Mass Q-TOF LC/MS spectrometer. The spectrometer was calibrated before each chromatographic run for optimal mass accuracy. The mobile phase gradient was 100% acetonitrile, at a flow rate of 0.5 ml/min. The mass spectra were acquired in positive- or negative-ion mode with source temperature at 300 °C. Ion spray voltage and fragmentor voltage were adjusted to 3.5 kV and 175 V, respectively. The range of mass detected was between 100 m/z and 1000 m/z.
2.3.2. Data processing
HRMS profiles were acquired and processed using MassHunter B.07 software. The obtained spectra were then exported as images.
Acknowledgments
We thank the funding support from the Research Grants Council of the Hong Kong Special Administrative Region, China (PolyU 251000/17M and 151000/19M), Hong Kong Polytechnic University internal grants (G-YBYY, 1-ZVPS and large equipment fund) and State Key Laboratory of Chemical Biology and Drug Discovery.
Footnotes
Supplementary data related to this article can be found at https://doi.org/10.1016/j.dib.2020.105313.
Conflict of Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Appendix A. Supplementary data
The following are the supplementary data related to this article:
References
- 1.Ma C., Yang X., Lewis P.J. Bacterial transcription as a target for antibacterial drug development. Microbiol. Mol. Biol. Rev. 2016;80:139–160. doi: 10.1128/MMBR.00055-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Yang X., Luo M.J., Yeung A.C.M., Lewis P.J., Chan P.K.S., Ip M., Ma C. First-in-class inhibitor of ribosomal RNA synthesis with antimicrobial activity against Staphylococcus aureus. Biochemistry. 2017;56:5049–5052. doi: 10.1021/acs.biochem.7b00349. [DOI] [PubMed] [Google Scholar]
- 3.Qiu Y., Chan S.T., Lin L., Shek T.L., Tsang T.F., Barua N., Zhang Y., Ip M., Chan P.K.-S., Blanchard N., Hanquet G., Zuo Z., Yang X., Ma C. Design, synthesis and biological evaluation of antimicrobial diarylimine and–amine compounds targeting the interaction between the bacterial NusB and NusE proteins. Eur. J. Med. Chem. 2019;178:214–231. doi: 10.1016/j.ejmech.2019.05.090. [DOI] [PubMed] [Google Scholar]
- 4.Qiu Y., Chan S.T., Lin L., Shek T.L., Tsang T.F., Zhang Y., Ip M., Chan P.K.-S., Blanchard N., Hanquet G., Zuo Z., Yang X., Ma C. Nusbiarylins, a new class of antimicrobial agents: rational design of bacterial transcription inhibitors targeting the interaction between the NusB and NusE proteins. Bioorg. Chem. 2019;92:103203. doi: 10.1016/j.bioorg.2019.103203. [DOI] [PubMed] [Google Scholar]
- 5.Pauli G.F., Chen S.-N., Simmler C., Lankin D.C., Gödecke T., Jaki B.U., Friesen B.J., McAlpine J.B., Napolitano J.G. Importance of purity evaluation and the potential of quantitative 1H NMR as a purity assay. J. Med. Chem. 2014;57:9220–9231. doi: 10.1021/jm500734a. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


